Linfocitos B reguladores en enfermedades humanas y modelos murinos de autoinmunidad

Kumar, 2006, Current perspectives on primary immunodeficiency diseases, Clin Dev Immunol, 13, 223, 10.1080/17402520600800705 Levy, 1997, Clinical spectrum of X-linked hyper-IgM syndrome, J Pediatr, 131, 47, 10.1016/S0022-3476(97)70123-9 Jesus, 2008, Autoimmunity in hyper-IgM syndrome, J Clin Immunol, 28, S62, 10.1007/s10875-008-9171-x Durandy, 2005, Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects, Immunol Rev, 203, 67, 10.1111/j.0105-2896.2005.00222.x Zhang, 2007, Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: Clinical and immunologic outcomes in heterozygotes, J Allergy Clin Immunol, 120, 1178, 10.1016/j.jaci.2007.10.001 Arason, 2010, Primary immunodeficiency and autoimmunity: Lessons from human diseases, Scand J Immunol, 71, 317, 10.1111/j.1365-3083.2010.02386.x Jacob, 2008, Autoimmunity in IgA deficiency: Revisiting the role of IgA as a silent housekeeper, J Clin Immunol, 28, S56, 10.1007/s10875-007-9163-2 Neta, 1974, Specific suppression of delayed hypersensitivity: The possible presence of a suppressor B cell in the regulation of delayed hypersensitivity, J Immunol, 113, 1716, 10.4049/jimmunol.113.6.1716 Sistigu, 2011, Immunomodulatory effects of cyclophosphamide and implementations for vaccine design, Semin Immunopathol, 33, 369, 10.1007/s00281-011-0245-0 Wolf, 1996, Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice, J Exp Med, 184, 2271, 10.1084/jem.184.6.2271 Fillatreau, 2002, B cells regulate autoimmunity by provision of IL-10, Nat Immunol, 3, 944, 10.1038/ni833 Zorro, 2009, Response to ODN-CpG by B Cells from patients with systemic lupus erythematosus correlates with disease activity, Lupus, 18, 718, 10.1177/0961203309103098 Lampropoulou, 2008, TLR-activated B cells suppress T cell-mediated autoimmunity, J Immunol, 180, 4763, 10.4049/jimmunol.180.7.4763 Matsushita, 2006, Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response, Am J Pathol, 168, 812, 10.2353/ajpath.2006.050923 Mann, 2007, B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis, J Immunol, 178, 3447, 10.4049/jimmunol.178.6.3447 Mizoguchi, 1997, Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice, J Exp Med, 186, 1749, 10.1084/jem.186.10.1749 Mizoguchi, 2002, Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation, Immunity, 16, 219, 10.1016/S1074-7613(02)00274-1 Tian, 2001, Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice, J Immunol, 167, 1081, 10.4049/jimmunol.167.2.1081 Hussain, 2007, Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner, J Immunol, 179, 7225, 10.4049/jimmunol.179.11.7225 Mauri, 2003, Prevention of arthritis by interleukin 10-producing B cells, J Exp Med, 197, 489, 10.1084/jem.20021293 Gray, 2007, Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells, Proc Natl Acad Sci U S A, 104, 14080, 10.1073/pnas.0700326104 Yanaba, 2008, A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses, Immunity, 28, 639, 10.1016/j.immuni.2008.03.017 Yanaba, 2009, The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals, J Immunol, 182, 7459, 10.4049/jimmunol.0900270 Maseda, 2012, Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo, J Immunol, 188, 1036, 10.4049/jimmunol.1102500 Litvack, 2011, IgM promotes the clearance of small particles and apoptotic microparticles by macrophages, PLoS One, 6, e17223, 10.1371/journal.pone.0017223 Matsushita, 2010, Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis, J Immunol, 185, 2240, 10.4049/jimmunol.1001307 Yoshizaki, 2012, Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions, Nature, 491, 264, 10.1038/nature11501 Watanabe, 2010, Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity, J Immunol, 184, 4801, 10.4049/jimmunol.0902385 Yanaba, 2011, IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model, Am J Pathol, 178, 735, 10.1016/j.ajpath.2010.10.022 Yang, 2012, IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation, Am J Pathol, 180, 2375, 10.1016/j.ajpath.2012.03.010 Evans, 2007, Novel suppressive function of transitional 2 B cells in experimental arthritis, J Immunol, 178, 7868, 10.4049/jimmunol.178.12.7868 Carter, 2012, Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis, Arthritis Res Ther, 14, R32, 10.1186/ar3736 Carter, 2011, Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells, J Immunol, 186, 5569, 10.4049/jimmunol.1100284 Blair, 2009, Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice, J Immunol, 182, 3492, 10.4049/jimmunol.0803052 Brisslert, 2006, Phenotypic and functional characterization of human CD25+ B cells, Immunology, 117, 548, 10.1111/j.1365-2567.2006.02331.x Kessel, 2012, Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells, Autoimmun Rev, 11, 670, 10.1016/j.autrev.2011.11.018 Blair, 2010, CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients, Immunity, 32, 129, 10.1016/j.immuni.2009.11.009 Lemoine, 2011, Human T cells induce their own regulation through activation of B cells, J Autoimmun, 36, 228, 10.1016/j.jaut.2011.01.005 Leandro, 2006, Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis, Arthritis Rheum, 54, 613, 10.1002/art.21617 Flores-Borja, 2013, CD19+CD24hiCD38hi B Ccells maintain regulatory T cells while limiting TH1 and TH17 differentiation, Sci Transl Med, 5, 173ra23, 10.1126/scitranslmed.3005407 Iwata, 2011, Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, 117, 530, 10.1182/blood-2010-07-294249 Zha, 2012, Decrease in Proportion of CD19(+)CD24(hi)CD27(+) B Cells and Impairment of their suppressive function in Graves’ disease, PLoS One, 7, e49835, 10.1371/journal.pone.0049835 Klinker, 2012, Multiple mechanisms of immune suppression by B lymphocytes, Mol Med, 18, 123, 10.2119/molmed.2011.00333 Godfrey, 2004, Going both ways: Immune regulation via CD1d-dependent NKT cells, J Clin Invest, 114, 1379, 10.1172/JCI200423594 Van de Veen, 2013, IgG production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses, J Allergy Clin Immunol, 10.1016/j.jaci.2013.01.014 Horikawa, 2011, Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice, J Clin Invest, 121, 4268, 10.1172/JCI59266